CYTRX Community Page | What other sites are saying about CYTRX

CYTRX

(NQ: CYTR)

2.400 USD -0.020 (-0.83%)

Streaming Delayed Price / Updated: 12:25 PM EDT, May 21, 2013 / Add to My Watchlist

(CYTR) Community Analysis from

READ MORE (CYTR)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 21, 2013

Sickle Cell Knocks Out NFL Player. Can these Companies Help?

(Benzinga, 1/4/12)

Sickle cell disease is debilitating to millions of Americans, including Pittsburgh Steelers safety Ryan Clark. Although Clark only has one copy of the sickle cell gene -...(read more)

CytRx Corporation: A Unique Pharmaceutical Small Cap

(Value Investing, 6/19/11)

Cytrx Corporation Investment Overview Cytrx, a micro, undervalued biopharmaceutical company, currently has three main high potential drugs in its pipeline. Recently, Bloomberg BusinessWeek highlighted the effectiveness of...(read more)

CytRx Corporation Stock Review

(Wall Street Sector Selector, 5/19/11)

In another installment of highlighting various investment opportunities, today, I’m going to cover CytRx Corporation (ticker: CYTR). As a biotech guy myself, I’m always interested in up and...(read more)

View all posts about CytRx (CYTR)

CytRx (CYTR) Company Overview

There is no analysis for CYTR yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates